(888) 552-6760 SCHEDULE AN APPOINTMENT

Gagandeep Singh,

MD, FACS

Chief of Surgical Oncology and Director of Surgical Services, City of Hope Phoenix

COH Avatar Physician

My aim is to develop a very thoughtful, effective and forceful approach to beating cancer, working with our outstanding multidisciplinary team.

Location
City of Hope Phoenix
14200 West Celebrate Life Way
Goodyear, AZ 85338
Specialties
Surgical Oncology
Hepatobiliary and Pancreatic Surgery
Neuroendocrine Tumors
Education
Medical school:

Medical School Graduation (MBBS), Mahatma Gandhi Institute of Medical Sciences, Nagpur University, India

Residency:

General Surgery Residency in the U.S. - Chief Resident: Maricopa Medical Center, Phoenix, AZ, and Resident in Surgery: Maricopa Medical Center, Phoenix, AZ

Surgical Residency/ PG Training outside U.S. - Royal Liverpool University Hospital, Liverpool, UK and Tata Memorial Hospital & Cancer Center, University of Bombay, India

Fellowship:

Clinical Fellow (Transplant) - University of Iowa Hospitals & Clinics, Iowa City, IA

Belfer Fellow (Research) - Marion Bessin Liver Center, Albert Einstein College of Medicine, New York, NY

Fellow (HPB/ Surg Onc) - Hôpital Cochin, René Descartes University, Paris, France

Clinical Fellow (Surgical Oncology) - Tata Memorial Hospital & Cancer Center, University of Bombay, Bombay, India

Research Fellow (Surgical Oncology) - Tata Memorial Hospital & Cancer Center, University of Bombay, Bombay, India

Advanced degrees:

Diplome d’Etudes Approfondies: Masters in Surgical Sciences (Surgical Oncology), Hôpital Cochin, René Descartes University, Paris, France

Master of Surgery: Board Certification in General Surgery, Tata Memorial Hospital and Cancer Centre, University of Bombay, India

Certifications

Diplomate of the American Board of Surgery - Board Certification in General Surgery, U.S.

American Society of Transplant Surgery - Solid Organ Transplant Surgery Certification

About Me

Gagandeep “Gaugs” Singh, MD, FACS, joined City of Hope® Cancer Center Phoenix in May 2024 as its Chief of Surgical Oncology and Director of Surgical Services, bringing more than two decades’ experience as an internationally renowned pancreatic and liver cancer surgeon and a health care leader. He is also the head of the Hepatobiliary and Pancreatic Surgery and Neuroendocrine Tumor programs.

Dr. Singh takes a dynamic and compassionate approach to working with patients. His expertise includes treating tumors of the pancreas, liver, neuroendocrine and gastrointestinal systems, including a focus on complex robotic techniques and resections with vascular reconstruction. His goal is to make every patient’s experience as effective and comfortable as possible through a personalized approach to care that incorporates leading-edge treatments. He’s spearheaded multiple innovative projects that have led to the development of new open and minimally invasive robotic surgical techniques for complex and advanced-stage cancers.

“I enjoy challenging myself to use my expertise in resecting complex liver metastases/cancers and pancreatic cancers involving vascular reconstructions providing state-of-the-art options for patients who are often deemed inoperable,” Dr. Singh says.

His academic career began at the Keck School of Medicine at the University of Southern California. From there, Dr. Singh was appointed as director of the John Wayne Cancer Institute’s Liver and Pancreas Center in Santa Monica, California, where he served as chair of the Cancer Committee and vice president for fellowship education. In 2010, City of Hope Duarte asked Dr. Singh to spearhead its liver and pancreatic cancer program. During this time, he was named the chief of the Division of Surgical Oncology, a role that led the program to national recognition.

Dr. Singh earned his medical degree at the Mahatma Gandhi Institute of Medical Sciences in India, after which he completed multiple fellowships and residencies at some of the world’s top cancer centers and hospitals in India, the United Kingdom, France and the United States. He is a board-certified surgeon whose expertise keeps him in demand at conferences and association meetings around the country, and he has been included on multiple lists of “America’s Top Surgeons,” “Best Doctors of America” and “Super Doctors.”

Dr. Singh is a translational clinician-scientist, collaborating with bench scientists. His research has led to a number of peer-reviewed papers and patents for new medical technologies and techniques. He has published on a wide range of topics, such as complex liver resection for metastases, robotic surgical techniques and vascular reconstruction after pancreatic surgery and early-detection blood tests for pancreatic and colorectal cancers.

In his free time, Dr. Singh enjoys spending time with his family, hiking and creating artworks that incorporate computer chips. In addition to English, he is fluent in French, Hindi, Punjabi and Marathi.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.